Abivax S.a. buy DerAlmanach100000
Start price
08.06.25
/
100%
€7.10
Target price
08.06.28
€139.00
Performance (%)
1477.46%
Price
15.12.25
€101.00
Summary
This prediction is currently active. With a performance of 1477.46% the BUY prediction by DerAlmanach100000 is a big success. This prediction currently runs until 08.06.28. The prediction end date can be changed by DerAlmanach100000 at any time. DerAlmanach100000 has 100% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abivax S.a. | - | - |
| iShares Core DAX® | 0.795% | 1.458% |
| iShares Nasdaq 100 | -3.088% | -0.762% |
| iShares Nikkei 225® | -0.952% | -2.268% |
| iShares S&P 500 | -1.393% | 0.199% |
According to DerAlmanach100000 what are the pros and cons of Abivax S.a. for the foreseeable future?
Pros
Revenue growth > 30% per year expected
Rising EBIT margin expected
Very high dividend yield expected
Top Rating
ROE higher than 15% per year
Small challenges to pay loans and raise capital
Very good company culture
Very differentiated customer and product portfolio
Growths much faster than the competition
Management is a major shareholder
Small Risks for its business
Well known brand
Market Leader or Top 3
Very Future proof/growth oriented business model
EBIT growth > 30% per year expected
Undervalued
Very positive Cash Flow expected
High Investments for future growth
Very valuable balance sheet
Leading role in innovation
Strong uniques
Sustainability is very important
Cons
Comments by DerAlmanach100000 for this prediction
In the thread Abivax S.a. diskutieren
Kursziel gesetzt auf 139,0
Impfstoff gegen, HIV VIRUS "IST EUCH KLAR WIEVIEL DER WERT IST
🙉 DIE MARKTKAPITALISIERUNG AKTUELL.....ICH
LÄCHERLICH
MFG DERALMANACH100000
🙉 DIE MARKTKAPITALISIERUNG AKTUELL.....ICH
LÄCHERLICH
MFG DERALMANACH100000